PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Tissue loss triggers regeneration in planarian flatworms

2013-09-03
(Press-News.org) CAMBRIDGE, Mass. (September 3, 2013) – Unlike humans, planarian flatworms have the remarkable ability to regrow any missing body part, making them an ideal model with which to study the molecular basis of regeneration.

Over the years scientists have learned that planarians mount recovery responses that differ depending on the severity of the injury they suffer. For example, a worm with a cut or a puncture wound reacts at the cellular and molecular levels quite differently from one that loses its head or tail. What has remained unclear, however, is just exactly how these responses are triggered.

Whitehead Institute Member Peter Reddien and two of his former graduate students, Michael Gaviño and Danielle Wenemoser, address this longstanding question this week in the journal eLife, revealing a fascinating interplay of signals between two wound-induced genes.

According to the work of Gavino, Wenemoser, and Reddien, regeneration initiation in planarians is regulated by the expression of the genes Smed-follistatin (or fst) and Smed-activin-1 and -2 (or act-1 and act-2), that together act like a switch. After a planarian is wounded, the type of injury determines the level fst expression——the more extreme the loss of tissue, the higher the level of fst expressed. At puncture wounds, fst expression is low, and regeneration is inhibited. However, following amputation, which results in major loss of tissue, fst levels rise and in turn inhibit Activin proteins, allowing regeneration to begin.

To the researchers' surprise, this interaction only affects regeneration and healing related to injury. Normal maintenance and cell turnover throughout the planarian body continue unaffected when fst is inhibited, even though these activities rely on the same neoblast cell population that creates new tissue during regeneration.

"It's a really great phenotype," says Reddien, who is also a Howard Hughes Medical Institute Early Career Scientist and an associate professor of biology at Massachusetts Institute of Technology. "It's one of the dream phenotypes—to have a defect that's regeneration-specific, where the neoblasts are working. It's just regeneration that isn't working."

Such a phenotype could be a powerful tool in the further exploration of mechanisms that control regeneration. And many questions about these mechanisms remain.

"For example, the animals know how far to grow in regeneration, so they don't make tumorous outgrowths," says Wenemoser, who is now a postdoctoral researcher at Stanford University. "There's some kind of regulation on homeostatic size, so they're not growing out all wild and crazy. There's definitely more to investigate there."

Gaviño agrees, and points out that the fst/act-1/2 switch may ultimately help scientists tease apart regeneration in other organisms, including humans.

"This regulation by activin and follistatin may be conserved in other systems," says Gaviño, who is currently a postdoctoral researcher at Univeristy of California, San Francisco. "There are a lot of hints in the scientific literature that versions of activin or follistatin or both are activated by injury and may play a role in regeneration in other animals, but pinning the role of initiating regeneration to them hasn't happened yet."

###

This work was supported by the National Institutes of Health grant R01GM080639 and the Keck Foundation.

Written by Nicole Giese Rura

Peter Reddien's primary affiliation is with Whitehead Institute for Biomedical Research, where his laboratory is located and all his research is conducted. He is also a Howard Hughes Medical Institute Early Career Scientist and an associate professor of biology at Massachusetts Institute of Technology.

Full Citation:

"Tissue absence initiates regeneration through Follistatin-mediated inhibition of Activin signaling"

eLife, online on September 10, 2013.

Michael A. Gaviño (1), Danielle Wenemoser (1), Irving E. Wang (1), and Peter Reddien (1).

1. Howard Hughes Medical Institute, Whitehead Institute, and Department of Biology, Massachusetts Institute of Technology, 9 Cambridge Center, Cambridge, MA 02142, USA.

END



ELSE PRESS RELEASES FROM THIS DATE:

French Tour de France cyclists live longer than their non-cyclist countrymen

2013-09-03
AMSTERDAM, The Netherlands – French participants in the Tour de France between 1947-2012 lived longer than their same-age French counterparts according to the results of a study marking the centenary of the race this year. "In the context of recent concerns regarding performance-enhancing techniques and the potential negative health effects of excessive high-level physical activity, data on the long-term outcomes and causes of death in elite endurance cyclists is of particular interest," said Xavier Jouven, MD, PhD, from the Sudden Death Expertise Center in Paris, France. "Although ...

Biomarker assessment in suspected ACS could be practice-changing: BIC-8 results

2013-09-03
AMSTERDAM, The Netherlands – An emergency department strategy that uses two biomarkers to triage patients with suspected acute coronary syndrome (ACS) can increase the rate of early, safe hospital discharge, according to results of the Biomarkers in Cardiology 8 (BIC-8) trial. "This biomarker strategy using a state-of-the-art quantitative troponin assay in combination with an ultrasensitive copeptin assay has the potential to change clinical practice with high patient safety," said lead investigator Martin Möckel, MD, PhD, from Charité - Universitätsmedizin Berlin, in ...

Despite missing primary efficacy endpoint, ATOMIC-AHF identifies positive trends

2013-09-03
AMSTERDAM, The Netherlands – Omecamtiv mecarbil, a cardiac myosin-activator, did not achieve its primary efficacy endpoint in reducing dyspnoea (shortness of breath) in patients with acute heart failure, according to the results of the phase II ATOMIC-AHF (Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure) study. However, a cohort which received the highest dose of the drug showed greater dyspnoea relief compared with placebo, and there were also other favourable dose and concentration-related trends, noted lead investigator John ...

Hot Line IV: Late-breaking trials on heart failure and acute coronary syndrome

2013-09-03
AMSTERDAM, The Netherlands – The blood pressure lowering drug aliskiren did not improve coronary artery disease when given to patients who had prehypertension, results of the Aliskiren Quantitative Atherosclerosis Regression Intravascular Ultrasound Study (AQUARIUS) reveal. The findings, reported at the European Society of Cardiology Congress with simultaneous publication in the Journal of the American Medical Association, offer new insight into the value of lowering blood pressure beyond prehypertensive goals, suggested lead investigator Stephen Nicholls MBBS, PhD, Deputy ...

TAVI is safe alternative to redo cardiac surgery

2013-09-02
Use of bioprosthetic heart valves has dramatically increased (from 18% in 1991 to 59% in 2003), mainly in older patients with comorbidities. This is due to the increased risk of bleeding complications associated with lifelong use of anticoagulation for mechanical prostheses. But structural valve deterioration is one the main complications associated with bioprosthetic heart valves. In large registries including more than 300 000 patients undergoing aortic valve replacement the reoperation rate for patients receiving a bioprosthesis was 3.1% at 11-13 years of follow-up ...

Women less likely to die after TAVI than men

2013-09-02
Dr Sherif said: "Earlier studies on the impact of gender on outcome after transcatheter aortic valve implantation (TAVI) have had conflicting results. A Canadian study reported in 641 consecutive patients that female sex is associated with a better long-term and short-term survival after TAVI.1 An Italian study of 305 high risk patients found no gender differences in composite safety and efficacy endpoints at 30 days and one year after TAVI."2 The current analysis examined gender differences in outcomes for 1432 consecutive patients from 27 centers who were enrolled in ...

TAVI feasible in bicuspid aortic valve

2013-09-02
Bicuspid aortic valve (BV) is the most common congenital valvular abnormality, occurring in 1-2% of the general population. Two of the aortic valvular leaflets fuse during development resulting in a valve that is bicuspid instead of the normal tricuspid configuration. BV is associated with increased mechanical stress which predisposes to calcification and development of aortic stenosis which narrows the opening of the aortic valve. Dr Bauer said: "TAVI is used to treat elderly high risk patients with severe aortic stenosis. Despite previous assumptions the frequency of ...

Health of older women in developed countries continues to improve

2013-09-02
Measures taken in developed countries to reduce noncommunicable diseases – the leading causes of death globally – have improved the life expectancy of women aged 50 years and older over the last 20 to 30 years. But, according to a study that will be published in the Bulletin of the World Health Organization on 2 September, the gap in life expectancy between such women in rich and poor countries is growing. The WHO study, one of a collection of articles in a special issue of the journal devoted to women's health beyond reproduction, found that the leading causes of death ...

Stomach bacteria switch off human immune defences to cause disease

2013-09-02
Helicobacter pylori is a bacterium that establishes a life-long stomach infection in humans, which in some cases can lead to duodenal ulcers or stomach cancer. New research, presented at this week's Society for General Microbiology Autumn Conference, gives us a clearer understanding of how these bacteria can manipulate the human immune system to survive in the mucosal lining of the stomach. Researchers from the University of Nottingham have shown that H. pylori is able to supress the body's normal production of 'human beta defensin 1' (hβD1), an antimicrobial factor ...

Scientists discover novel functions of platelets

2013-09-02
OKLAHOMA CITY, September 1, 2013 — A new finding could lead to novel treatments to reduce bleeding in trauma and severe infections. The research, from Oklahoma Medical Research Foundation scientists Lijun Xia, M.D., Ph.D., Jianxin Fu, M.D., Ph.D., and Brett Herzog, Ph.D., appears in the most recent issue of the journal Nature. One way the immune system keeps a body healthy is through immune surveillance. Lymphocytes, a type of white blood cell, constantly exit the bloodstream and "check in" at the lymph nodes to learn about possible pathogens or abnormal cell growth. ...

LAST 30 PRESS RELEASES:

Revolutionary scandium doping technique extends sodium-ion battery life

High-fat diet impairs memory formation by reducing autophagy

Keck Hospital of USC named a Vizient Top Performer for third year in a row

New CRISPR test could make tuberculosis screening as simple as a mouth swab

Three-sensor overeating detection could reshape obesity treatment

Study provides first evidence that plastic nanoparticles can accumulate in the edible parts of vegetables

AI predicts complications from surgery better than doctors

New personalized risk score could improve ovarian cancer detection

People on Ozempic who eat to regulate emotions less likely to lose weight

AACR Cancer Progress Report highlights lifesaving impact of federal investments in cancer research

Indra's internet

Lymph nodes found to be key to successful cancer immunotherapy

Room-temperature terahertz device opens door to 6G networks

A hard look at geoengineering reveals global risks

When smoke signals danger: How Australian lizards evolved to escape fire

Beyond the surface: Atopic eczema linked to significantly higher risk of suicidal thoughts, major study finds

After weight loss regular exercise rather than GLP-1 weight-loss drug reduces leading cause of heart attack and strokes

EASD launches its first ever clinical practice guideline – the world’s first to focus on diabetes distress

Semaglutide provides powerful protection against diabetic retinopathy, the leading cause of blindness in working-age adults, Greek study suggests

Orforglipron taken orally once daily leads to significant body weight loss (ATTAIN-1 Study)

U of I researchers trace genetic code’s origins to early protein structures

Disease experts team up with Florida Museum of Natural History to create a forecast for West Nile virus

Researchers: Targeted efforts needed to stem fentanyl crisis

New UMaine research could help lower prescription drug costs

Molecular movie shows how mitochondria read their DNA

Loss of key male fertility gene leads to changes in expression of hundreds of other genes

Water’s density is key to sustainable lithium mining

Pioneering research reveals problem gambling quadruples the risk of suicide among young people four years later

New method improves the accuracy of machine-learned potentials for simulating catalysts

Astronomers discover rare Einstein cross with fifth image, revealing hidden dark matter

[Press-News.org] Tissue loss triggers regeneration in planarian flatworms